Kayne Anderson Rudnick Investment Management LLC Biomea Fusion, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$3.0 - $12.03 $369 - $1,479	-123 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.39 - $9.03 $539 - $1,110	123 New	123 $1,000

Others Institutions Holding BMEA

# of Institutions

104

Shares Held

17.8M

Call Options Held

1.68M

Put Options Held

410K

Cormorant Asset Management, LP Boston, MA

3.57M
Shares

$26 Million
2.53% of portfolio
Black Rock Inc. New York, NY

2.34M
Shares

$17 Million
0.0% of portfolio
Baker Bros. Advisors LP New York, NY

2.11M
Shares

$15.3 Million
0.23% of portfolio
Vanguard Group Inc Valley Forge, PA

1.4M
Shares

$10.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.38M
Shares

$10 Million
0.01% of portfolio

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $213M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account